Biology of breast cancer bone metastasis
- PMID: 18059174
- DOI: 10.4161/cbt.7.1.5163
Biology of breast cancer bone metastasis
Abstract
Breast carcinoma ranks among the most prevalent malignancies in women. Breast carcinoma frequently metastasizes to bone and approximately 70% of patients with breast cancer have bone metastases, which generally are osteolytic lesions. They cause major morbidity and mortality in patients; and the available treatment options are limited. Bone-specific homing and colonization of cancer cells are important and interesting features of metastasis. There are complex and multiple steps in the process of bone metastasis; and the elaborate interaction between breast carcinoma and bone involves various cytokines, growth factors and cellular signals, which results in a vicious cycle and promotes tumor cell accumulation and osteolysis. Recent advances in molecular biology have resulted in major breakthroughs in our understanding of the pathogenesis of bone metastasis in breast cancer, which is critical in preventing metastasis, designing novel and targeted treatments and prolonging survival in this devastating condition.
Similar articles
-
Breast cancer metastasis to bone: it is not all about PTHrP.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S39-45. doi: 10.1097/01.blo.0000093844.72468.f4. Clin Orthop Relat Res. 2003. PMID: 14600591 Review.
-
Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):169-80. doi: 10.1007/s10911-005-5399-8. J Mammary Gland Biol Neoplasia. 2005. PMID: 16025223 Review.
-
[Bone-related events in breast cancer].Clin Calcium. 2008 Apr;18(4):447-54. Clin Calcium. 2008. PMID: 18379025 Review. Japanese.
-
Molecular mechanisms of osteolytic bone metastases.Cancer. 2000 Jun 15;88(12 Suppl):2892-8. doi: 10.1002/1097-0142(20000615)88:12+<2892::aid-cncr2>3.0.co;2-y. Cancer. 2000. PMID: 10898330 Review.
-
Mechanisms of osteolytic bone metastases in breast carcinoma.Cancer. 2003 Feb 1;97(3 Suppl):834-9. doi: 10.1002/cncr.11132. Cancer. 2003. PMID: 12548583 Review.
Cited by
-
The role of osteoblasts in bone metastasis.J Bone Oncol. 2016 Apr 13;5(3):124-127. doi: 10.1016/j.jbo.2016.03.007. eCollection 2016 Sep. J Bone Oncol. 2016. PMID: 27761372 Free PMC article.
-
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.Prog Mol Biol Transl Sci. 2010;95:31-53. doi: 10.1016/B978-0-12-385071-3.00003-4. Prog Mol Biol Transl Sci. 2010. PMID: 21075328 Free PMC article. Review.
-
Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling.Clin Exp Metastasis. 2021 Jun;38(3):321-335. doi: 10.1007/s10585-021-10093-z. Epub 2021 Mar 31. Clin Exp Metastasis. 2021. PMID: 33791875 Free PMC article.
-
TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.Cancer Biol Ther. 2011 Feb 1;11(3):311-6. doi: 10.4161/cbt.11.3.14096. Epub 2011 Feb 1. Cancer Biol Ther. 2011. PMID: 21099351 Free PMC article.
-
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.Breast Cancer Res. 2011 Oct 27;13(5):R106. doi: 10.1186/bcr3048. Breast Cancer Res. 2011. PMID: 22032690 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical